Azenta sale of B Medical Systems delayed due to financing issues

Azenta Inc. (NASDAQ: AZTA) announced that the sale of B Medical Systems S.À R.L. did not close by the March 31, 2026 deadline due to financing conditions not being met by the buyer.

Azenta Germany GmbH, a wholly owned subsidiary of Azenta, had entered into a definitive Sale and Purchase Agreement with Thelema S.À R.L. for the sale of the entire issued share capital of B Medical Systems S.À R.L. The transaction was originally expected to close on or before March 31, 2026.

On March 27, 2026, Thelema informed Azenta that it had not yet secured the financing required to complete the transaction. The buyer indicated it requires additional time to complete its financing arrangements.

The transaction remains subject to the satisfaction of all closing conditions, including Thelema securing the required financing. The parties have not amended or terminated the agreement, according to the company's statement.

Azenta stated it is evaluating potential paths forward regarding the transaction while Thelema continues to work on completing its financing arrangements. The company noted there is no assurance the transaction will be completed on a revised timeline or at all.

You May Also Be Interested In

• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• Ian Wendler to retire from Jewett-Cameron board by July 31
• Laser Photonics CEO takes leave, EVP named interim president